Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-19T18:45:21.820Z Has data issue: false hasContentIssue false
  • English
  • Français

The chicken and egg of anxiety and depression

Published online by Cambridge University Press:  11 May 2015

A. Schatzberg
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

Antianxiety agentsantidepressantsdepressionpharmacokinetics
Type
Commentaries to Special Article
Information
Epidemiology and Psychiatric Sciences , Volume 24 , Issue 3 , June 2015 , pp. 227 - 229
Copyright
Copyright © Cambridge University Press 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Arnow, BA, Blasey, C, Williams, LM, Palmer, D, Rekshan, W, Schatzberg, AF, Etkin, A, Kulkarni, J, Luther, JF, Rush, AJ (2015, in press). Are depression subtypes relevant to predicting antidepressant response?: a report from the iSPOT-D trial. American Journal of Psychiatry.CrossRefGoogle Scholar
Etkin, A, Schatzberg, AF (2011). Common abnormalities and disorder-specific compensation during implicit regulation of emotional processing in generalized anxiety and major depressive disorders. American Journal of Psychiatry 168, 968–978.CrossRefGoogle ScholarPubMed
Fava, M, Rush, AJ, Alpert, JE, Balasubramani, GK, Wisniewski, SR, Carmin, CN, Biggs, MM, Zisook, S, Leuchter, A, Howland, R, Warden, D, Trivedi, MH (2008). Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. American Journal of Psychiatry 165, 342–351.CrossRefGoogle ScholarPubMed
Hayward, C, Varady, S, Albano, AM, Thienemann, M, Henderson, L, Schatzberg, AF (2000). Cognitive-behavioral group therapy for social phobia in female adolescents: results of a pilot study. Journal of the American Academy Child of Adolescent Psychiatry 39, 721–726.Google Scholar
Magee, WJ, Eaton, WW, Wittchen, HU, McGonagle, KA, Kessler, RC (1996). Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Archives of General Psychiatry 53, 159–168.CrossRefGoogle ScholarPubMed
Montgomery, SA, Locklear, JC, Svedsäter, H, Eriksson, H (2014). Efficacy of once-daily extended release quetiapine fumarate in patients with different levels of severity of generalized anxiety disorder. International Clinical Psychopharmacology 29, 252–262.CrossRefGoogle ScholarPubMed
Oathes, DJ, Patenaude, B, Schatzberg, AF, Etkin, A (2015). Neurobiological signatures of anxiety and depression in resting-state functional magnetic resonance imaging. Biological Psychiatry 77, 385–393.Google Scholar
Ohayon, MM, Schatzberg, AF (2010). Social phobia and depression: prevalence and comorbidity. Journal of Psychosomatic Research 68, 235–243.Google Scholar
Oler, JA, Fox, AS, Shelton, SE, Rogers, J, Dyer, TD, Davidson, RJ, Shelledy, W, Oakes, TR, Blangero, J, Kalin, NH (2010). Amygdalar and hippocampal substrates of anxious temperament differ in their heritability. Nature 466, 864–868.Google Scholar
Papakostas, GI, Clain, A, Ameral, VE, Baer, L, Brintz, C, Smith, WT, Londborg, PD, Glaudin, V, Painter, JR, Fava, M (2010). Fluoxetine-clonazepam cotherapy for anxious depression: an exploratory, post-hoc analysis of a randomized, double blind study. International Journal of Clinical Psychopharmacology 25, 17–21.Google Scholar
Regier, DA, Rae, DS, Narrow, WE, Kaelber, CT, Schatzberg, AF (1998). Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. British Journal of Psychiatry Supplement 34, 24–28.Google Scholar
Rosenbaum, AH, Maruta, T, Schatzberg, AF, Orsulak, PJ, Jiang, NS, Cole, JO, Schildkraut, JJ (1983). Toward a biochemical classification of depressive disorders, VII: urinary free cortisol and urinary MHPG in depressions. American Journal of Psychiatry 140, 314–318.Google Scholar
Saveanu, R, Etkin, A, Duchemin, AM, Goldstein-Piekarski, A, Gyurak, A, Debattista, C, Schatzberg, AF, Sood, S, Day, CV, Palmer, DM, Rekshan, WR, Gordon, E, Rush, AJ, Williams, LM (2015). The International Study to Predict Optimized Treatment in Depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment. Journal of Psychiatric Research 61, 1–12.Google Scholar
Schatzberg, AF, Orsulak, PJ, Rosenbaum, AH, Maruta, T, Kruger, ER, Cole, JO, Schildkraut, JJ (1982). Toward a biochemical classification of depressive disorders, V: heterogeneity of unipolar depressions. American Journal of Psychiatry 139, 471–475.Google Scholar
Schatzberg, AF, Kremer, C, Rodrigues, HE, Murphy, GM Jr(2002). Mirtazapine vs. Paroxetine Study Group. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients. American Journal of Geriatric Psychiatry 10, 541–550.CrossRefGoogle Scholar